PepGen (PEPG) Total Current Liabilities (2021 - 2026)

PepGen (PEPG) reported Total Current Liabilities of $9.0 million for Q1 2026, down 56.13% on a YoY basis from $20.4 million in Q1 2025, and down 29.12% sequentially from $12.6 million in Q4 2025.

PepGen (PEPG) Total Current Liabilities (2021 - 2026) Analysis & Trends

PepGen (PEPG) has 6 years of Total Current Liabilities data on file, last reported at $9.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Current Liabilities fell 56.13% year-over-year to $9.0 million; the trailing twelve-month figure through Mar 2026 stood at $9.0 million (down 56.13% YoY), and the FY2025 full-year result was $12.6 million, down 24.26% from the prior year.
  • Total Current Liabilities fell to $9.0 million in Q1 2026, from $12.6 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $22.1 million in Q2 2024 to a low of $9.0 million in Q1 2026.
  • A 5-year average of $16.6 million and a median of $16.8 million in 2024 frame the typical range for Total Current Liabilities.
  • Across the five-year window, Total Current Liabilities surged 82.42% in 2022 and tumbled 56.13% in 2026, its largest moves.
  • Tracing PEPG's Total Current Liabilities over 5 years: stood at $18.8 million in 2022, then retreated by 6.89% to $17.5 million in 2023, then dropped by 4.76% to $16.7 million in 2024, then retreated by 24.26% to $12.6 million in 2025, then retreated by 29.12% to $9.0 million in 2026.
  • Business Quant data shows PEPG's Total Current Liabilities at $9.0 million in Q1 2026, $12.6 million in Q4 2025, and $12.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 56.01 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 66.94 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 13.42 Mn
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.81 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 289.60 Mn
10 PepGen 133.00 Mn 133.00 Mn - 8.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.96 Mn
Dec 31, 2025 12.65 Mn
Sep 30, 2025 12.64 Mn
Jun 30, 2025 16.36 Mn
Mar 31, 2025 20.43 Mn
Dec 31, 2024 16.70 Mn
Sep 30, 2024 16.81 Mn
Jun 30, 2024 22.11 Mn
Mar 31, 2024 11.26 Mn
Dec 31, 2023 17.53 Mn
Sep 30, 2023 20.96 Mn
Jun 30, 2023 16.94 Mn
Mar 31, 2023 18.03 Mn
Dec 31, 2022 18.83 Mn
Sep 30, 2022 15.52 Mn
Jun 30, 2022 20.58 Mn
Mar 31, 2022 16.12 Mn
Dec 31, 2021 10.32 Mn